4
Views
8
CrossRef citations to date
0
Altmetric
Original Article

Antagonist Study in St. Louis

, &
Pages 379-390 | Published online: 07 Jul 2009

References

  • Wilder A. Conditioning factors in opiate addiction and relapse. Narcotics, D. M. Wilmer, G. G. Kasselbaum. McGraw-Hill, New York 1965
  • Lindesmith A. R. Problems in social psychology of addiction. Narcotics, D. M. Wilmer, G. G. Kasselbaum. McGraw-Hill, New York 1965
  • Martin W. R., Gorodetzky C. W., McClane T. K. An experimental study in the treatment of narcotic addicts with cyclazocine. Clin. Pharmacol. Ther. Jaunary, 1966; 7: 455–465
  • Jaffe J. H., Brill L. Cyclazocinea long acting narcotic antagonist; its voluntary acceptance as a treatment modality by narcotic abusers. Int. J. Addict. 1966; 1: 99–123
  • Freedman A. M., Fink M., Sharoff R., Zaks A. Cyclazocine and methadone in narcotic addiction. J. Am. Med. Assoc. 1967; 202: 119–122
  • Zaks A., et al. Naloxone treatment of opiate dependence; a progress report. J. Am. Med. Assoc. 1971; 215: 2108–2110
  • Kleinman P. (1974) Early age of onset of heroin addiction: A first investigation of some social determinants, Columbia University 1974. Paper Presented at the meeting of the Society for the Study of Social Problems. 1974. MontrealCanada
  • Vaillant G. A twelve year followup of New York narcotic addicts. IV. Am. J. Psychiatry November, 1966; 123(5)573–588

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.